Fox Run Management’s Halozyme HALO Stock Holding History

Fox Run Management’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-10,778	Closed	-$670K	–	1085
2026 Q1	$670K	Buy	+10,778	New	+$760K	0.12%	315
2025 Q4	–	Sell	-12,312	Closed	-$903K	–	1042
2025 Q3	$903K	Sell	12,312 -3,910	-24%	-$260K	0.14%	249
2025 Q2	$844K	Buy	+16,222	New	+$923K	0.14%	248
2025 Q1	–	Sell	-10,224	Closed	-$489K	–	1029
2024 Q4	$489K	Buy	+10,224	New	+$524K	0.09%	442
2024 Q3	–	Sell	-5,001	Closed	-$262K	–	926
2024 Q2	$262K	Sell	5,001 -11,848	-70%	-$520K	0.05%	584
2024 Q1	$685K	Buy	+16,849	New	+$632K	0.15%	264
2023 Q4	–	Sell	-17,510	Closed	-$669K	–	835
2023 Q3	$669K	Buy	+17,510	New	+$717K	0.2%	172
2022 Q3	–	Sell	-7,639	Closed	-$336K	–	701
2022 Q2	$336K	Buy	+7,639	New	+$330K	0.17%	254
2019 Q1	–	Sell	-10,313	Closed	-$151K	–	562
2018 Q4	$151K	Sell	10,313 -7,652	-43%	-$122K	0.08%	442
2018 Q3	$326K	Buy	+17,965	New	+$315K	0.14%	323
2018 Q2	–	Sell	-12,429	Closed	-$243K	–	770
2018 Q1	$243K	Sell	12,429 -25,916	-68%	-$502K	0.06%	567
2017 Q4	$777K	Buy	38,345 +21,445	+127%	+$394K	0.23%	125
2017 Q3	$294K	Buy	+16,900	New	+$229K	0.08%	500

Other funds holding HALO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Fox Run Management's HALO Position: Q2 2026 in Review

Fox Run Management sold out of Halozyme (HALO) in Q2 2026, closing a stake of 10,778 shares — an estimated $670K sold.

Fox Run Management first reported a position in HALO in Q3 2017 and held it in 13 quarters. The position peaked at $903K in Q3 2025. 671 funds tracked by Wall St. Rank hold HALO as of Q2 2026.

Fox Run Management reported no remaining Halozyme position as of Q2 2026 after selling out during the quarter.
Fox Run Management sold 10,778 Halozyme shares in Q2 2026, an estimated $670K.
Fox Run Management first reported a position in Halozyme in Q3 2017 and held it in 13 quarters.
Fox Run Management's Halozyme position peaked at $903K in Q3 2025.
671 funds tracked by Wall St. Rank held Halozyme as of Q2 2026.

Based on Fox Run Management's 13F filing for Q2 2026, filed 4 Aug 2026.